Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [ Kidney Int. Rep. 2021; https://doi.org/10.1016/j.ekir.2021.08.020]

Affiliations

• ¹ Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
• ² Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan.
• ³ R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
• ⁴ Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
• ⁵ Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.